December 20, 2017

Biovotec has successfully completed its preclinical safety studies and is now ready to apply for its clinical studies, see attached for more information. 

Please reload

Media Contact:     +47 95 94 99 78

Recent Posts
Please reload

Archive
Please reload

Engebrets vei 3, 0275 Oslo, Norway                                                   © Biovotec AS                                                                       info@biovotec